other material
confidence high
sentiment neutral
materiality 0.35
ORIC Pharmaceuticals amends inducement equity plan, adds 1.1M shares to reserve
Oric Pharmaceuticals, Inc.
- Compensation Committee approved Amended and Restated 2022 Inducement Plan, adding 1,100,000 shares to reserve.
- Total shares reserved under the plan increased to 2,250,000 shares.
- Amendment adopted without stockholder approval under Nasdaq Listing Rules.
- Awards are inducement material for new employees and non-employee directors under Nasdaq Rule 5635(c)(4).